Mrs. Pamela Ann Pendleton, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 539 Grant Rd, Brooks, GA 30205 Phone: 404-307-7058 Fax: 770-460-9002 |
Mrs. Laura Hicks Wilkinson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 130 Dukes Ct, Brooks, GA 30205 Phone: 770-716-0099 |
News Archive
Researchers in Mexico, New Zealand and Italy have conducted a modeling study suggesting that the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) being transmitted via indoor vaping is not significantly higher than the risk associated with other types of expiration.
The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.
Researchers believe they have found a way to change the action of 60 percent of currently available medications, in some cases making them many times more effective, according to an article published in the April 21 edition of the journal Science. The discovery has the potential to improve treatments for diseases including heart disease, cancer, diabetes, depression and arthritis. The study describes a new way to manipulate perhaps the most important signaling mechanism in human cells: G-protein coupled receptors (GPCRs).
Compounds from hops may combat metabolic syndrome by changing the gut microbiome and altering the metabolism of acids produced in the liver, new research at Oregon State University suggests.
The recent announcement that Celebrex, a popular pain drug in the same family as Vioxx, has been found to pose an increased risk of heart problems is bound to leave many pain patients stunned, confused and worried.
› Verified 2 days ago